Aug. 15, 2017 — The U.S, Food and Drug Administration (FDA) granted market clearance for the HAART 200 Aortic Annuloplasty Device, the first annuloplasty device designed specifically for bicuspid aortic valve repair. With FDA clearance of both the HAART 300 and HAART 200 Aortic Annuloplasty Devices, BioStable Science and Engineering Inc. is now able to offer U.S. surgeons a comprehensive portfolio of aortic valve repair solutions that addresses all forms of aortic valve insufficiency. 

Hypertrophic Cardiomyopathy (HCM) Summit

Read an updated version of this article with more detail from CMS — "CMS to Cancel Mandatory Cardiac Bundled Payments and Cardiac Rehabilitation Payment Model."
 

Aug. 14, 2017 — The Centers for Medicare and Medicaid Services (CMS) may eliminate the cardiac rehabilitation incentive payments and orthopedic bundled payments that were planned to go into effect Jan. 1, 2018. 

Cardiology Fiesta Symposium

Cases and Controversies in Cardiovascular Disease

International Conference on Cardiovascular Medicine and Cardiac Surgery

International Academy of Cardiology

August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-generation imaging analysis technology.

Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for medical professionals on the go. The Clarius App 3.1 Eclipse with the enhancements is available now on the App Store and Google Play.

Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-based repair system for treating people with moderate or severe tricuspid regurgitation (TR). The first patient was enrolled at Abbott Northwestern Hospital by Paul Sorajja, M.D., cardiologist at Minneapolis Heart Institute and Abbott Northwestern Hospital.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now